NA-Semax-Amidate dosage

NA-Semax-Amidate intranasal dosage

Reported-use amounts for NA-Semax-Amidate are 300–600 mcg / day, 1–2x daily, for 2–4 wk.[8]

N-Acetyl Semax Amidate has terminal modifications that distinguish it from unmodified Semax. Semax product directions cannot establish equivalent exposure for this derivative.[1][2][3][8]

NA-Semax-Amidate injectable dosage

Reported-use amounts for NA-Semax-Amidate are ~250 mcg per administration, daily, for 2–4 wk.[8]

N-Acetyl Semax Amidate has terminal modifications that distinguish it from unmodified Semax. Semax product directions cannot establish equivalent exposure for this derivative.[1][2][3][8]

Frequency and timing

Nasal patterns list morning or early-afternoon timing. The injection pattern lists morning administration.[4][1][2][8]

Cycle length and breaks

Intranasal: 2–4 wk. Injectable: 2–4 wk. A standard break interval between courses is not established.[8]

Approval and product quality

NA-Semax-Amidate is not an FDA-approved drug.[4][5][6][7]

Side effects and long-term safety

Local nasal irritation, headache, neurostimulation and sleep disruption are relevant tolerability concerns. Derivative-specific human safety, dose-ranging, interactions and long-term intranasal use remain poorly characterized.[1][2][3][4]

Route-specific dosing limits

Derivative-specific evidence, anxiety/sleep sensitivity, and formulation quality drive the cautions. Reported-use intranasal and injectable schedules are not established human treatment regimens.[1][2][3][4][8]